Log in

PolicyFinancial Express

OPPI warns frequent drug price cuts may deter pharma investments

Negative-67

GreyOak summary

OPPI cautions that frequent government price cuts of 25-50% under Para 19 of DPCO 2013 could disrupt business plans and discourage investments. The association urges selective use of the provision and suggests strengthening reimbursement frameworks instead of relying solely on price reductions.

What it affects

  • HealthcareNegative -67

    Frequent price cuts may deter pharma investments.Rolling sentiment Positive +29

Source

Read the original at Financial Express

More news

All news →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy